Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 2530-2538, October 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vesselinovitch, S. D.
Right arrow Articles by Lombard, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vesselinovitch, S. D.
Right arrow Articles by Lombard, L. S.

Development of Broad Spectrum of Tumors by Ethylnitrosourea in Mice and the Modifying Role of Age, Sex, and Strain1

S. D. Vesselinovitch, K. V. N. Rao, N. Mihailovich, J. M. Rice and L. S. Lombard

Department of Radiology [S. D. V., K. V. N. R., N. M.], and Department of Pathology [S. D. V., L. S. L.], The Pritzker School of Medicine, and Franklin McLean Memorial Research Institute [S. D. V.], University of Chicago,2 Chicago, Illinois 60637, and Experimental Pathology Branch, National Cancer Institute, Bethesda, Maryland 20014 [J. M. R.]

The modifying role of age, sex, and strain upon the incidence, multiplicity, and spectrum of tumors induced by ethylnitrosourea, a short-acting carcinogen, has been studied. The first-generation (F1) hybrids of C57BL/6J x C3HeB/FeJ and C3HeB/FeJ x A/J mice of both sexes were given single i.p. injections (60 or 120 µg/g) of ethylnitrosourea at 1, 15, or 42 days of age. Experimental animals were left to live their life-span, while the control groups were killed at 52, 90, 142, and 170 weeks of age, respectively.

Animals treated with ethylnitrosourea died, in general, by the 90th week of age due to development of tumors mainly in lung, liver, Harderian glands, stomach, ovaries, lymphoreticular system, kidneys, mammary gland, uterus, and nervous system. In contrast, few of the controls died during that same observational period.

The age of mice at the time of exposure to the carcinogen was one of the most important modifiers of tumor development in lung, liver, Harderian glands, stomach, kidneys, lymphoreticular system, nervous system, ovaries, and mammary glands. The sex of the animals influenced the development of liver tumors, Harderian gland tumors, and malignant lymphomas. The C3HeB/FeJ x A/J F1 hybrids more readily developed lung tumors, while the C57BL/6 x C3HeB/FeJ F1 mice were more susceptible to liver, Harderian gland, lymphoreticular system, ovarian, and mammary gland carcinogenesis.

1 These investigations have been supported in part by Contract NIH-NCI-E-69-2087 from the National Cancer Institute; Grant 69-6 from the American Cancer Society, Illinois Division, Inc.; American Cancer Society Institutional Grant ACS-IN-41-I; General Research Support Grant USPHS-5-501; and USPHS Grant 5-PO6-RR-00409.

2 Operated by the University of Chicago for the United States Atomic Energy Commission.

Received 11/ 5/73. Accepted 6/12/74.




This article has been cited by other articles:


Home page
Toxicol SciHome page
W. Slikker III, N. Mei, and T. Chen
N-Ethyl-N-nitrosourea (ENU) Increased Brain Mutations in Prenatal and Neonatal Mice but Not in the Adults
Toxicol. Sci., September 1, 2004; 81(1): 112 - 120.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Li, Z. H. Meng, A. Sayeed, R. Shalaby, B.-M. Ljung, and S. H. Dairkee
Genome-wide Allelotyping of a New in Vitro Model System Reveals Early Events in Breast Cancer Progression
Cancer Res., October 15, 2002; 62(20): 5980 - 5987.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. M. Bugni, T. M. Poole, and N. R. Drinkwater
The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility
Carcinogenesis, November 1, 2001; 22(11): 1853 - 1862.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Mitsumori, H. Onodera, T. Shimo, K. Yasuhara, H. Takagi, T. Koujitani, M. Hirose, C. Maruyama, and S. Wakana
Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea
Carcinogenesis, May 1, 2000; 21(5): 1039 - 1042.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.